ACE2 and viral infectious disease: Since the spike protein plays a major role in initializing viral infection through binding to ACE2, inhibiting the binding of the spike protein to ACE2 is an attractive strategy for developing drugs to block the spread of SARS-CoV-2 infection and treat COVID-19 (Das et al., 2020; Wu et al., 2020).